BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiao ZJ, Gao JJ, Hua SH, Chen DY, Wang WH, Wang H, Wang XH, Xu HX. Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer. World J Gastroenterol 2012; 18(38): 5454-5461 [PMID: 23082063 DOI: 10.3748/wjg.v18.i38.5454]
URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5454.htm
Number Citing Articles
1
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, Tatiana Correa Carneiro-Lobo, Sabah Akhtar, Kodappully Sivaraman Siveen, Nissar A. Wani, Arshi Rizwan, Puneet Bagga, Mayank Singh, Ravinder Reddy, Shahab Uddin, Jean-Charles Grivel, Gyan Chand, Michael P. Frenneaux, Mushtaq A. Siddiqi, Davide Bedognetti, Wael El-Rifai, Muzafar A. Macha, Mohammad Haris. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapyMolecular Cancer 2021; 20(1) doi: 10.1186/s12943-020-01294-3
2
K. Gabrusiewicz, N.A. Colwell, A.B. Heimberger. Translational Immunotherapy of Brain Tumors2017; : 63 doi: 10.1016/B978-0-12-802420-1.00004-1
3
Karolina Okla, Iwona Wertel, Anna Wawruszak, Marcin Bobiński, Jan Kotarski. Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells – is a new era coming?Critical Reviews in Clinical Laboratory Sciences 2018; 55(6): 376 doi: 10.1080/10408363.2018.1477729
4
Kiran H. Lagisetty, Dyke P. McEwen, Derek J. Nancarrow, Johnathon G. Schiebel, Daysha Ferrer-Torres, Dipankar Ray, Timothy L. Frankel, Jules Lin, Andrew C. Chang, Laura A. Kresty, David G. Beer. Immune determinants of Barrett’s progression to esophageal adenocarcinomaJCI Insight 2021; 6(1) doi: 10.1172/jci.insight.143888
5
Ruoting Zheng, Shiyi Chen, Shenren Chen. Correlation between myeloid-derived suppressor cells and S100A8/A9 in tumor and autoimmune diseasesInternational Immunopharmacology 2015; 29(2): 919 doi: 10.1016/j.intimp.2015.10.014
6
Liang Wen, Ping Gong, Chao Liang, Dawei Shou, Baoqing Liu, Yiwen Chen, Changqian Bao, Li Chen, Xiaowei Liu, Tingbo Liang, Weihua Gong. Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?Oncotarget 2016; 7(23): 35490 doi: 10.18632/oncotarget.8204
7
Maham Farshidpour, Monjur Ahmed, Shilpa Junna, Juanita L Merchant. Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic reviewWorld Journal of Gastrointestinal Oncology 2021; 13(1): 1-11 doi: 10.4251/wjgo.v13.i1.1
8
Hiroshi Katoh. Systemic Drug Delivery Strategies2022; : 409 doi: 10.1016/B978-0-323-85781-9.00015-4
9
Lisa Christiansson, Stina Söderlund, Emma Svensson, Satu Mustjoki, Mats Bengtsson, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S. I. Loskog, Gobardhan Das. Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid LeukemiaPLoS ONE 2013; 8(1): e55818 doi: 10.1371/journal.pone.0055818
10
丽葶 黄. The Role of MDSCs in Digestive System Tumors and Research Progress in Targeted TherapyAdvances in Clinical Medicine 2024; 14(09): 925 doi: 10.12677/acm.2024.1492548
11
M.E. Kavanagh, K.E. O’Sullivan, C. O’Hanlon, J.N. O’Sullivan, J. Lysaght, J.V. Reynolds. The esophagitis to adenocarcinoma sequence; the role of inflammationCancer Letters 2014; 345(2): 182 doi: 10.1016/j.canlet.2013.08.017
12
E W Lin, T A Karakasheva, P D Hicks, A J Bass, A K Rustgi. The tumor microenvironment in esophageal cancerOncogene 2016; 35(41): 5337 doi: 10.1038/onc.2016.34
13
Martin Borgmann, Michael Quante. Impact of the Tumor Microenvironment for Esophageal Tumor Development—An Opportunity for Prevention?Cancers 2022; 14(9): 2246 doi: 10.3390/cancers14092246
14
Prince Amoah Barnie, Pan Zhang, Hongxiang Lv, Dan Wang, Xiaolian Su, Zhaoliang Su, Huaxi Xu. Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disordersExperimental and Therapeutic Medicine 2017; 13(2): 378 doi: 10.3892/etm.2016.4018
15
Ya‐Wen Lo, Alan Yueh‐Luen Lee, Yi‐Ching Liu, Hui‐Hsin Ko, Hsin‐Hui Peng, Hsiang‐Chieh Lee, Pei‐Yao Pan, Chun‐Pin Chiang, Shih‐Jung Cheng. β‐glucan therapy converts the inhibition of myeloid‐derived suppressor cells in oral cancer patientsOral Diseases 2022; 28(6): 1484 doi: 10.1111/odi.13827
16
Masoud H. Manjili, Xiang-Yang Wang, Scott Abrams. Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to MregsFrontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00303
17
Cirino Botta, Annamaria Gullà, Pierpaolo Correale, Pierosandro Tagliaferri, Pierfrancesco Tassone. Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational OpportunitiesFrontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00348
18
Hiroshi Katoh, Masahiko Watanabe, Analía Trevani. Myeloid‐Derived Suppressor Cells and Therapeutic Strategies in CancerMediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/159269
19
Michael R Olin, Walter Low, David H McKenna, Stephen J Haines, Tambra Dahlheimer, David Nascene, Michael P Gustafson, Allan B Dietz, H Brent Clark, Wei Chen, Bruce Blazar, John R Ohlfest, Christopher Moertel. Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4+IL17+ responseJournal for ImmunoTherapy of Cancer 2014; 2(1) doi: 10.1186/2051-1426-2-4
20
Jingwei Jiang, Weijian Guo, Xiaohua Liang. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patientsHuman Immunology 2014; 75(11): 1128 doi: 10.1016/j.humimm.2014.09.025
21
Mohamed Labib Salem, Abdel-Aziz A. Zidan, Mohamed Attia, Randa E. EL-Naggar, Mohamed Nassef, Abdel Raouf Abou El-Azm, Hasan El-Bate, Mohamed Yussif, Sohaila Galal, Mohamed Abo Senna, Maha El Demellawy. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOSImmunopharmacology and Immunotoxicology 2017; 39(4): 188 doi: 10.1080/08923973.2017.1320670
22
Eric Jou, Natasha Chaudhury, Fizza Nasim. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatmentExploration of Targeted Anti-tumor Therapy 2024; 5(1): 187 doi: 10.37349/etat.2024.00212
23
Xiao-Jun Zhang, Yan Yu, He-Ping Zhao, Lei Guo, Kun Dai, Jing Lv. Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancerWorld Journal of Gastroenterology 2024; 30(16): 2195-2208 doi: 10.3748/wjg.v30.i16.2195
24
Sunanda Rajkumari, Jaspreet Singh, Usha Agrawal, Sandeep Agrawal. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectivesInternational Immunopharmacology 2024; 142: 112949 doi: 10.1016/j.intimp.2024.112949